Intrinsic Value of S&P & Nasdaq Contact Us

Dynavax Technologies Corporation DVAX NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
71/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$31.00
+100%

Dynavax Technologies Corporation (DVAX) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 9 Buy, 1 Hold, 1 Sell.

The consensus price target is $31.00, representing an upside of 100% from the current price $15.50.

DVAX Stock — 12-Month Price Forecast

$31.00
▲ +100.00% Upside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for Dynavax Technologies Corporation, the price target is $31.00.
The average price target represents a +100.00% change from the last price of $15.50.

DVAX Analyst Ratings

Buy
11
Ratings
9 Buy
1 Hold
1 Sell
Based on 11 analysts giving stock ratings to Dynavax Technologies Corporation in the past 3 months
Rating breakdown
Buy
9 82%
Hold
1 9%
Sell
1 9%
82%
Buy
9 analysts
9%
Hold
1 analysts
9%
Sell
1 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message